Pharma Business Week articles from October 2003

Pharma Business Week archives from October 2003

Positive results of preclinical trials of AZ-CINN 310 released.
October 6, 2003... 2003 OCT 6 - (NewsRx.com & NewsRx.net) -- CryoLife, Inc.'s (CRY), subsidiary, Aurazyme Pharmaceuticals, Inc., announced that in preclinical animal trials AZ-CINN-310 demonstrated accelerated destruction of breast cancer tumor cells at the site...

AERx pain management system study data published.
October 6, 2003... 2003 OCT 6 - (NewsRx.com & NewsRx.net) -- Researchers, led by scientists at Aradigm Corporation, (ARDM) published results of a clinical study involving the AERx Pain Management System in the September 2003 issue of the journal Anesthesiology....

GeneMax Corp. announces agreement for the production of TAP cancer vaccine.
October 6, 2003... 2003 OCT 6 - (NewsRx.com & NewsRx.net) -- GeneMax Corp. (GMXX) announced an amended contractual agreement with Molecular Medicine BioServices, Inc., of San Diego, California, for the production of its clinical vector for delivery of the TAP...

Positive phase III results for bicifadine, a novel, non-narcotic analgesic, announced.
October 6, 2003... 2003 OCT 6 - (NewsRx.com & NewsRx.net) -- DOV Pharmaceutical, Inc., (DOVP) announced positive efficacy and safety results for its phase III clinical trial investigating its novel, non-narcotic analgesic, bicifadine, in the treatment of moderate...

Launching blockbusters: Early investments fuel maximum impact.
October 6, 2003... 2003 OCT 6 - (NewsRx.com & NewsRx.net) -- To boost market uptake to a maximum first-year peak, successful pharmaceutical executives ramp up investments in prelaunch marketing activities, according to a study from pharmaceutical research firm...

Promising results reported on new protease activated therapy.
October 6, 2003... 2003 OCT 6 - (NewsRx.com & NewsRx.net) -- Dendreon Corporation (DNDN) announced that it will present data on a lead compound from its new Protease Activated Therapy (PACT) therapeutic platform. In preclinical testing to date, the compound,...

Incyte enters licensing agreement for a phase II HIV drug.
October 6, 2003... 2003 OCT 6 - (NewsRx.com & NewsRx.net) -- Incyte Corp. (INCY) and Pharmasset, Ltd., announced that they have entered into a collaborative licensing agreement to develop and commercialize the antiretroviral drug Reverset, also known as RVT,...

FDA clears BLU-U Blue Light Photodynamic Therapy Illuminator.
October 6, 2003... 2003 OCT 6 - (NewsRx.com & NewsRx.net) -- DUSA Pharmaceuticals, Inc., (DUSA) reported that on September 9, 2003, it received 510(k) marketing clearance from the U.S. Food and Drug Administration (FDA) for the BLU-U Blue Light Photodynamic...

Experimental drug for allergic rhinitis studied in multidose safety trial.
October 6, 2003... 2003 OCT 6 - (NewsRx.com & NewsRx.net) -- Rigel Pharmaceuticals, Inc., (RIGL) has initiated a multidose safety trial of R112, an experimental drug to treat allergic rhinitis, to establish the longer-term, multi-dose safety of R112 in various...

Test available to track Alzheimer progression and response to treatment.
October 6, 2003... 2003 OCT 6 - (NewsRx.com & NewsRx.net) -- Nymox Pharmaceutical Corporation (NYMX)'s AlzheimAlert test product has shown through study data that it can accurately detect Alzheimers disease on the same patient multiple times over a 3-year time...

Novel drug candidate shows promise in treating neurodegenerative diseases.
October 6, 2003... 2003 OCT 6 - (NewsRx.com & NewsRx.net) -- Pharmacyclics, Inc. (PCYC) announced the presentation of promising findings from preclinical studies of a novel drug candidate to treat neurodegenerative diseases based on its proprietary texaphyrin...

Innovative Medical enters partnership to develop, market Axenohl-based products.
October 6, 2003... 2003 OCT 6 - (NewsRx.com & NewsRx.net) -- Innovative Medical Services (PURE) has signed an agreement with Therapeutics, Inc., a drug development company based in La Jolla, California, for the development and commercialization of U.S. Food and...

Initiative achieves significant antibiotic prescription cost savings.
October 6, 2003... 2003 OCT 6 - (NewsRx.com & NewsRx.net) -- The Health Action Council of Northeast Ohio and Caremark, Inc., have demonstrated that prescription drug expenses, one of the fastest growing components of healthcare costs, can be reduced while...

Amelioration of asthma symptoms reported with anti-C5 therapy.
October 6, 2003... 2003 OCT 6 - (NewsRx.com & NewsRx.net) -- Alexion Pharmaceuticals, Inc., (ALXN) is reporting that anti-C5 monoclonal antibody therapy blocked the development of bronchial inflammation and reduced airway hyperresponsiveness in preclinical models...

Asthma attacks at school are disruptive to routine, under-diagnosed.
October 6, 2003... 2003 OCT 6 - (NewsRx.com & NewsRx.net) -- According to a national sample of members surveyed from the National Association of School Nurses, asthma is more disruptive of school routines than any other chronic condition and has a significant...

SinusPharma recognized as a top Rising Star company by Deloitte & Touche.
October 6, 2003... 2003 OCT 6 - (NewsRx.com & NewsRx.net) -- SinusPharma, provider of specialty pharmaceuticals and doctor/patient services for the treatment of chronic sinus disorders, won the top Rising Star company award in Deloitte & Touche's 2003 Los Angeles...

Study findings suggest strategy for regeneration of tissues in damaged brains.
October 6, 2003... 2003 OCT 6 - (NewsRx.com & NewsRx.net) -- Curis, Inc., (CRIS) announced that the current issue of the scientific journal Neuron contains a report demonstrating that the Hedgehog signaling pathway is required for the formation and maintenance of...

Epimmune earns milestone payment under cancer epitope license.
October 6, 2003... 2003 OCT 6 - (NewsRx.com & NewsRx.net) -- Epimmune, Inc., (EPMN) announced that it has earned and received a milestone payment from Anosys, Inc., as a result of Anosys' filing of an IND for a product incorporating Epimmune technology under a...

Research aims to understand how mistakes in DNA replication lead to disease.
October 6, 2003... 2003 OCT 6 - (NewsRx.com & NewsRx.net) -- Studies at the University of Houston (UH) are shedding light on the mechanisms our bodies use to recognize and repair mistakes in our genetic code, mistakes that, left unchecked, could lead to cancer....

Oral drug delivery research alliance signed.
October 6, 2003... 2003 OCT 6 - (NewsRx.com & NewsRx.net) -- Access Pharmaceuticals, Inc., (AKC) has entered into a research collaboration in oral drug delivery with the Celltech Group plc (CLL, CCH), of Slough, England. The goal of the collaboration is to...

Research agreement focuses on central nervous system and metabolic disease agents.
October 6, 2003... 2003 OCT 6 - (NewsRx.com & NewsRx.net) -- Scynexis, Inc., has broadened the scope and extended the term of its research agreement with Roche to discover and develop compounds for central nervous system and metabolic diseases. The...

Enrollment complete for efficacy study of constipation treatment drug.
October 6, 2003... 2003 OCT 6 - (NewsRx.com & NewsRx.net) -- Sucampo Pharmaceuticals, Inc., involved in functional fatty acid research and development, has completed enrollment for the last of two phase III efficacy studies to support the new drug application...

Pharmaceutical DTC marketing costs will reach up to $80 million by 2005.
October 6, 2003... 2003 OCT 6 - (NewsRx.com & NewsRx.net) -- The pharmaceutical industry continues to invest more in direct-to-consumer (DTC) marketing each year and total spending will range between $70 and $80 million by 2005, according to a report by...

Intranasal vitamin B-12 supplement approved by FDA.
October 6, 2003... 2003 OCT 6 - (NewsRx.com & NewsRx.net) -- Questcor Pharmaceuticals, Inc. (QSC), a specialty pharmaceutical company, announced that the company has received a letter from the U.S. Food and Drug Administration (FDA) approving the company's...

Generic version of Paxil launched.
October 6, 2003... 2003 OCT 6 - (NewsRx.com & NewsRx.net) -- Apotex Corp. announced that it has launched paroxetine hydrochloride tablets, 10 mg, 20 mg, 30 mg, and 40 mg. The U.S. Food and Drug Administration has determined that Apotex' paroxetine tablets...

Trial shows Probactrix is effective for treating diarrhea caused by antibiotics.
October 6, 2003... 2003 OCT 6 - (NewsRx.com & NewsRx.net) -- The BioBalance Corp., a wholly owned subsidiary of New York Health Care (BBAL), released the results of a randomized clinical study in which a formulation containing its proprietary biotherapeutic...

Mexican distributor granted exclusive rights for Microcyn 60.
October 6, 2003... 2003 OCT 6 - (NewsRx.com & NewsRx.net) -- Oculus Technologies of Mexico, S.A., de C.V., a subsidiary of Oculus Innovative Sciences, announced the finalization of an exclusive agreement with Quimica Pasteur, S. De RL., for distribution of...

$2M grant awarded for development of drug research software.
October 6, 2003... 2003 OCT 6 - (NewsRx.com & NewsRx.net) -- Targacept, Inc., has been awarded a grant from the National Institute of Standards and Technology (NIST) through its Advanced Technology Program (ATP) that will provide approximately $2 million over a...

Biotechnology and pharmaceutical companies co-developing new anticancer drug.
October 6, 2003... 2003 OCT 6 - (NewsRx.com & NewsRx.net) -- OncoGenex Technologies, Inc., and Isis Pharmaceuticals, Inc., (ISIS) have expanded their antisense drug development partnership to include the development of the second-generation antisense anticancer...

Merck enters alliance to apply RNA interference for human therapeutics.
October 6, 2003... 2003 OCT 6 - (NewsRx.com & NewsRx.net) -- Merck & Co., Inc., (MRK) and Alnylam Holding Co., an RNA interference (RNAi) company, announced that they have entered into a multiyear collaboration to develop RNAi-based technology and therapeutics....

Pharmaceutical corporation anticipates up to four new investigational drugs.
October 6, 2003... 2003 OCT 6 - (NewsRx.com & NewsRx.net) -- Nymox Pharmaceutical Corporation (NYMX) announced the company's management anticipates filing up to four investigational new drug applications (INDs) for new products in the next 12 months and plans to...

New information management system available for pharma, biotech firms.
October 6, 2003... 2003 OCT 6 - (NewsRx.com & NewsRx.net) -- Accelrys, a wholly owned subsidiary of Pharmacopeia, Inc., (PCOP), announced the release of its latest solutions for chemical and biological information management: Accord Enterprise Informatics and DS...

Acquisition of pharmaceutical company completed.
October 6, 2003... 2003 OCT 6 - (NewsRx.com & NewsRx.net) -- Ampersand Ventures, a venture capital firm with approximately $600 million under management in four target sectors, including life sciences, announced that ArQule, Inc., has completed its acquisition of...

American Stock Exchange lists oncology company's stock.
October 6, 2003... 2003 OCT 6 - (NewsRx.com & NewsRx.net) -- The American Stock Exchange (AMEX) listed the common stock of Bioenvision, Inc., under the ticker symbol BIV. Bioenvision primarily focuses on the acquisition, development, and distribution of...

Angiotech to change fiscal year end financials to calendar year.
October 6, 2003... 2003 OCT 6 - (NewsRx.com & NewsRx.net) -- Angiotech Pharmaceuticals, Inc., (ANPI; ANP) announced that it intends to change its fiscal year end from September 30 to December 31, effective as of December 31, 2003. This step is being taken to...

Dialysis company calls 7% convertible notes, authorizes share repurchase.
October 6, 2003... 2003 OCT 6 - (NewsRx.com & NewsRx.net) -- DaVita, Inc., (DVA) announced that it is calling for redemption the remainder of its 7% convertible subordinated notes due 2009. The aggregate principal amount outstanding of the Notes is $145...

Pharmaceutical company's stock listed on AMEX.
October 6, 2003... 2003 OCT 6 - (NewsRx.com & NewsRx.net) -- The American Stock Exchange (AMEX) listed the common stock of Pro-Pharmaceuticals, Inc. (PRW). Pro-Pharmaceuticals, Inc., is a drug development company commercializing a new generation of...

Revised financial expectations reported by pharmaceutical company.
October 6, 2003... 2003 OCT 6 - (NewsRx.com & NewsRx.net) -- Alpharma, Inc., (ALO), a leading global specialty pharmaceutical company, announced revised expectations for the second half and full year 2003. The company currently expects third quarter 2003...

Topical drug company announces $3.25 million private placement.
October 6, 2003... 2003 OCT 6 - (NewsRx.com & NewsRx.net) -- MacroChem Corp. (MCHM) announced that it has raised approximately $3.25 million in gross proceeds from a private placement of its securities, primarily to institutional investors. MacroChem is a...

Venture financing round completed with Emerging Technology Partners.
October 6, 2003... 2003 OCT 6 - (NewsRx.com & NewsRx.net) -- Adenosine Therapeutics, LLC, announced the completion of a round of venture financing with the Emerging Technology Partners of Rockville, Maryland. In the transaction, the company also acquired...

GSK makes announcement regarding launch of generic paroxetine hydrochloride.
October 6, 2003... 2003 OCT 6 - (NewsRx.com & NewsRx.net) -- GlaxoSmithKline (GSK) confirmed that a generic form of paroxetine hydrochloride was launched by Apotex Corp. on September 8, 2003, triggering GSK's license agreement with Par Pharmaceutical, Inc. ...

Report: Insurers won't reimburse weight-loss treatment; cite lack of data.
October 6, 2003... 2003 OCT 6 - (NewsRx.com & NewsRx.net) -- Decision Resources, Inc., has issued a report indicating that the obese population is highly underserved. The inability of patients to maintain weight loss with currently available therapies drives...

Acetaminophen may be best for patients on cardioprotective aspirin therapy.
October 6, 2003... 2003 OCT 6 - (NewsRx.com & NewsRx.net) -- Heart specialists say acetaminophen, the medicine in Tylenol, may be the best choice over-the-counter pain reliever for the millions of Americans taking aspirin to protect against cardiovascular...

FDA clearance granted for new D-10 Hemoglobin testing system.
October 6, 2003... 2003 OCT 6 - (NewsRx.com & NewsRx.net) -- Bio-Rad Laboratories, Inc., (BIO; BIO.B) has received 510(k) clearance from the U.S. Food and Drug Administration (FDA) for its D-10 Hemoglobin A1c system that includes both the D-10 instrument and...

Agreement signed with Baxter for Advate distribution.
October 6, 2003... 2003 OCT 6 - (NewsRx.com & NewsRx.net) -- Curative Health Services, Inc., (CURE) announced that it has signed a multiyear supply agreement with Baxter Healthcare Corporation for Advate (Antihemophilic Factor (Recombinant), Plasma/Albumin-Free...

U.S. commercial availability of Advate announced.
October 6, 2003... 2003 OCT 6 - (NewsRx.com & NewsRx.net) -- Following its recent U.S. launch of Advate, Antihemophilic Factor (Recombinant), Plasma/Albumin-Free Method, (rAHF-PFM), Baxter Healthcare Corporation (BAX) announced that it has signed non-exclusive...

Clinical trials of Coagulin-B to resume.
October 6, 2003... 2003 OCT 6 - (NewsRx.com & NewsRx.net) -- Avigen, Inc., (AVGN) announced that it has received approval to proceed with its phase I clinical trial of Coagulin-B for the treatment of hemophilia B from both the U.S. Food and Drug Administration...

Hepatitis vaccine approved for sale in Argentina.
October 6, 2003... 2003 OCT 6 - (NewsRx.com & NewsRx.net) -- Corixa Corporation (CRXA) announced the Argentinean approval of Supervax, Berna Biotech's prophylactic vaccine containing Corixa's synthetic RC-529 adjuvant, for the prevention of Hepatitis B infection....

Final FDA approval received for generic Glucotrol XL 5mg tablets.
October 6, 2003... 2003 OCT 6 - (NewsRx.com & NewsRx.net) -- Amarin Corporation plc (AMRN) confirmed that Watson Pharmaceuticals, Inc., (WPI), had received approval on its Abbreviated New Drug Application (ANDA) for 5 mg glipizide extended-release tablets from...

New drug application submitted for cinacalcet HCl.
October 6, 2003... 2003 OCT 6 - (NewsRx.com & NewsRx.net) -- Amgen (AMGN) filed a new drug application (NDA) with the U.S. Food & Drug Administration for cinacalcet HCl, a first-in-class oral calcimimetic agent, licensed from NPS Pharmaceuticals, Inc., currently...

Benicar HCT now available in U.S.
October 6, 2003... 2003 OCT 6 - (NewsRx.com & NewsRx.net) -- Sankyo Pharma, Inc., and Forest Laboratories, Inc., (FRX) announced that Benicar HCT (olmesartan medoxomil-hydrochlorothiazide) is now available via prescription in the United States. Benicar HCT...

FDA approves new manufacturing site for injectable testosterone product.
October 6, 2003... 2003 OCT 6 - (NewsRx.com & NewsRx.net) -- Savient Pharmaceuticals, Inc., (SVNT) announced that the U.S. Food and Drug Administration (FDA) has approved a new manufacturing site for the manufacture of Delatestryl (testosterone enanthate...

Changes in IV formula can reverse neurological problems in bowel failure patients.
October 6, 2003... 2003 OCT 6 - (NewsRx.com & NewsRx.net) -- Intravenous feedings may do well to provide patients with small bowel failure their required daily nutrition, but its long-term use can cause their liver to fail and Parkinson-like neurological...

Corixa Corp. signs research, development, and license agreement.
October 6, 2003... 2003 OCT 6 - (NewsRx.com & NewsRx.net) -- InNexus Biotechnology, Inc., (IXS), a monoclonal antibody-development company, and Corixa Corp. (CRXA), a developer of immunotherapeutic products, announced that the companies have entered into an...

Adults with asthma fail to follow flu vaccine guidelines.
October 6, 2003... 2003 OCT 6 - (NewsRx.com & NewsRx.net) -- Adults with asthma are considered a high risk group for developing complications after contracting the influenza virus, yet the majority of adults with asthma does not receive an annual influenza...

Alliance to bring added automation to Oracle clinical users.
October 6, 2003... 2003 OCT 6 - (NewsRx.com & NewsRx.net) -- BioPharm Systems, Inc., announced a partnership with Quovadx (QVDX) to introduce a new software and services offering that enhances the communications capabilities and automates key functions of Oracle...

Diabetes care moves online.
October 6, 2003... 2003 OCT 6 - (NewsRx.com & NewsRx.net) -- ConnectiCare and Medem announced the launch of a new service that will, for the first time, allow insured patients with diabetes to send their glucose readings to their own doctors securely via the...

Collaborative effort to develop inhaled insulin.
October 6, 2003... 2003 OCT 6 - (NewsRx.com & NewsRx.net) -- Bristol-Myers Squibb Company (BMY) and QDose, a joint venture between MicroDose Technologies, Inc., and Quadrant Drug Delivery, Ltd., announced that the companies have entered into a licensing agreement...

NIH provides grant for oral insulin development.
October 6, 2003... 2003 OCT 6 - (NewsRx.com & NewsRx.net) -- BioSante Pharmaceuticals, Inc., (BISP) announced that it has been awarded a $100,000 Small Business Innovation Research (SBIR) grant from the U.S. National Institutes of Health (NIH) to support the...

Label language finalized for Sucanon release in Mexico.
October 6, 2003... 2003 OCT 6 - (NewsRx.com & NewsRx.net) -- Robert Rieveley, president of Biotech Holdings (BIOHF.OB; BIO.V), reported that the finalized language for the Sucanon label has been submitted to Mexican regulators. "In the process of finalizing...

Composition patent for Sinusol filed.
October 6, 2003... 2003 OCT 6 - (NewsRx.com & NewsRx.net) -- Advanced Plant Pharmaceuticals, Inc., (APPI) a company that utilizes whole plants through a proprietary (patent pending) manufacturing process to develop nutraceuticals and supplements, has announced...

Patent issued covering cremophor-free taxanes.
October 6, 2003... 2003 OCT 6 - (NewsRx.com & NewsRx.net) -- American Pharmaceutical Partners, Inc., (APPX, APP) announced that U.S. Patent #6,506,405 was issued to American BioScience, Inc., (ABI), the privately held parent company of APP, and its inventors,...

Grants fund research on leukemia, lymphoma, and myeloma treatments.
October 6, 2003... 2003 OCT 6 - (NewsRx.com & NewsRx.net) -- The Leukemia & Lymphoma Society announced 32 Translational Research Program grants totaling $11.3 million to researchers on the forefront of developing new treatments for leukemia, lymphoma, and...

Rights to Loestrin oral contraceptive obtained.
October 6, 2003... 2003 OCT 6 - (NewsRx.com & NewsRx.net) -- Barr Laboratories, Inc., (BRL) and Galen Holdings PLC announced that they have signed a letter of intent for Barr to acquire from Galen the exclusive rights in the United States and Canada for Loestrin...

$464,000 Grant given to conduct research on lung cancer immunotherapy.
October 6, 2003... 2003 OCT 6 - (NewsRx.com & NewsRx.net) -- Peregrine Pharmaceuticals, Inc. (PPHM) announced that researchers at the Keck School of Medicine of the University of Southern California (USC) have received a $464,000 grant from Philip Morris External...

Antidepressant, proton pump inhibitor lead first half 2003 in drug promotion.
October 6, 2003... 2003 OCT 6 - (NewsRx.com & NewsRx.net) -- Forest Laboratories, Inc.'s, Lexapro and TAP Pharmaceuticals, Inc.'s, Prevacid were the prescription drugs most heavily promoted to managed care pharmacy directors during the first 6 months of 2003,...

Driving market uptake through successful physician messaging.
October 6, 2003... 2003 OCT 6 - (NewsRx.com & NewsRx.net) -- Executives at pharmaceutical companies consider major conferences and peer-reviewed journals as the best channels for communicating clinical trial results to physicians, according to a just-released...

Study: Market research critical to blockbuster launches.
October 6, 2003... 2003 OCT 6 - (NewsRx.com & NewsRx.net) -- In an increasingly competitive market, pharmaceutical companies invest more and more in market research to improve product positioning, according to a study from pharmaceutical research firm, Best...

AMA will provide electronic ethics alerts to physicians.
October 6, 2003... 2003 OCT 6 - (NewsRx.com & NewsRx.net) -- The American Medical Association announced that it will provide free "ethics alerts" to physicians via ePocrates' DocAlert system, a messaging system for personal digital assistants (PDAs). These...

Two clinical milestones achieved for Vitaxin.
October 6, 2003... 2003 OCT 6 - (NewsRx.com & NewsRx.net) -- Applied Molecular Evolution, Inc., (AME, AMEV) announced that it has achieved two separate milestones as a result of the initiation of phase II clinical trials for Vitaxin in both cancer and rheumatoid...

Acquisition offers company methods to fight bioterrorism.
October 6, 2003... 2003 OCT 6 - (NewsRx.com & NewsRx.net) -- Nutra Pharma Corp. (NPHC) has signed a letter of intent to acquire 100% of the capital stock of Infectech Inc. (IFEC) in a cash and stock transaction, providing Nutra Pharma with patented technologies...

Assets of Physicians Nutraceutical Laboratories acquired.
October 6, 2003... 2003 OCT 6 - (NewsRx.com & NewsRx.net) -- Bio-One Corporation (BICO) has acquired the assets of Florida based Physicians Nutraceutical Laboratories, Inc., in a transaction that includes a combination of cash and a royalty agreement. ...

Genzyme completes tender offer.
October 6, 2003... 2003 OCT 6 - (NewsRx.com & NewsRx.net) -- Genzyme Corp. (GENZ) announced that, through a wholly owned subsidiary, it has completed its tender offer to acquire outstanding shares of SangStat Medical Corp. (SANG) for $22.50 per share. ...

Martek completes acquisition of South Carolina company.
October 6, 2003... 2003 OCT 6 - (NewsRx.com & NewsRx.net) -- Martek Biosciences Corp. (MATK) announced that it has completed its planned acquisition of certain of the assets and assumption of certain of the liabilities of FermPro Manufacturing, L.P., of...

Peoples Genetics' technologies acquired for genetic analyses.
October 6, 2003... 2003 OCT 6 - (NewsRx.com & NewsRx.net) -- Beckman Coulter, Inc., (BEC) announced they have acquired the technologies of Peoples Genetics, Inc., (PGI) of Woburn, Massachusetts. The technologies are used for the comprehensive genetic analysis...

U.K. consumer dermatology business sold to Ferndale Pharmaceuticals.
October 6, 2003... 2003 OCT 6 - (NewsRx.com & NewsRx.net) -- Ecolab, Inc., announced that it has sold the consumer dermatology business of its Adams Healthcare subsidiary to Ferndale Pharmaceuticals, Ltd., in Leeds, United Kingdom. The annualized sales of...

Nanogen teams to develop infectious disease diagnostics.
October 6, 2003... 2003 OCT 6 - (NewsRx.com & NewsRx.net) -- Nanogen, Inc., (NGEN) and Prodesse, Inc., announced the signing of a collaboration agreement to develop automated, highly sensitive microarray-based products to detect a number of infectious disease...

Medicare panel supports Visudyne therapy for use in patients with occult AMD.
October 6, 2003... 2003 OCT 6 - (NewsRx.com & NewsRx.net) -- QLT, Inc., (QLT) announced a favorable vote by the Medicare Coverage Advisory Committee (MCAC) regarding questions relevant to the decision to be made by the U.S. Centers for Medicare and Medicaid...

New obesity drug in phase III development.
October 6, 2003... 2003 OCT 6 - (NewsRx.com & NewsRx.net) -- Regeneron Pharmaceuticals (REGN), a biopharmaceutical company that discovers, develops, and intends to commercialize therapeutic medicines for the treatment of serious medical conditions, announced that...

Grant to help fund cancer research.
October 6, 2003... 2003 OCT 6 - (NewsRx.com & NewsRx.net) -- Agencourt Bioscience Corporation, a provider of genomic services and nucleic acid purification products to the life sciences industry, announced that it is sponsoring a grant to help fund cancer...

Study demonstrates CG53135's activity in two animal models.
October 6, 2003... 2003 OCT 6 - (NewsRx.com & NewsRx.net) -- CuraGen Corporation (CRGN) announced that the results of a study on CG53135, the company's leading protein therapeutic in phase I clinical development, were published in the August 2003 edition of...

Territory expanded for Orthovisc to Germany and France.
October 6, 2003... 2003 OCT 6 - (NewsRx.com & NewsRx.net) -- Anika Therapeutics, Inc., (ANIK) announced that it has expanded its marketing and distribution partnership with Vita Research srl, based in Rome, Italy, for Orthovisc, Anika's treatment for...

Genetics company, UCSF to collaborate on osteoporosis genetics.
October 6, 2003... 2003 OCT 6 - (NewsRx.com & NewsRx.net) -- Interleukin Genetics, Inc., (ILGN) announced a collaboration with the University of California, San Francisco (UCSF) to understand the role of inflammation genetics in osteoporosis. The...

Royalty rights to R1549 obtained by U.K. biotech company.
October 6, 2003... 2003 OCT 6 - (NewsRx.com & NewsRx.net) -- Antisoma plc (ASOM, ASOM) and Cytogen Corporation (CYTO) announced that Antisoma has acquired certain royalty rights to Antisoma's lead product, R1549 (formerly Pemtumomab), from Cytogen. In...